Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

N-Acetyl GM3 vaccine

Drug Profile

N-Acetyl GM3 vaccine

Alternative Names: N-acetil GM3/VSSP; NAcetilGM3; NAcGM3-VSSP vaccine

Latest Information Update: 26 Aug 2016

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Center of Molecular Immunology
  • Developer Center of Molecular Immunology; Elea
  • Class AIDS vaccines; Cancer vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I/II HIV infections
  • Discontinued Breast cancer; Colorectal cancer; Lung cancer; Malignant melanoma

Most Recent Events

  • 18 Mar 2011 Clinical development is ongoing for Cancer and HIV infections in Cuba and Argentina
  • 26 Nov 2010 Phase-I/II clinical trials in Lung cancer in Argentina (Parenteral)
  • 28 Mar 2003 This vaccine is available for licensing (http://www.cim.sld.cu)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top